Northside Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-4,160
| Closed | -$291K | – | 95 |
|
2021
Q3 | $291K | Hold |
4,160
| – | – | 0.08% | 71 |
|
2021
Q2 | $286K | Sell |
4,160
-90
| -2% | -$6.19K | 0.07% | 73 |
|
2021
Q1 | $275K | Sell |
4,250
-325
| -7% | -$21K | 0.08% | 71 |
|
2020
Q4 | $267K | Sell |
4,575
-2,162
| -32% | -$126K | 0.08% | 71 |
|
2020
Q3 | $426K | Hold |
6,737
| – | – | 0.14% | 55 |
|
2020
Q2 | $518K | Hold |
6,737
| – | – | 0.18% | 61 |
|
2020
Q1 | $504K | Sell |
6,737
-140
| -2% | -$10.5K | 0.25% | 45 |
|
2019
Q4 | $447K | Sell |
6,877
-735
| -10% | -$47.8K | 0.15% | 60 |
|
2019
Q3 | $482K | Buy |
7,612
+77
| +1% | +$4.88K | 0.17% | 54 |
|
2019
Q2 | $509K | Buy |
7,535
+530
| +8% | +$35.8K | 0.2% | 42 |
|
2019
Q1 | $455K | Hold |
7,005
| – | – | 0.18% | 47 |
|
2018
Q4 | $438K | Buy |
7,005
+218
| +3% | +$13.6K | 0.19% | 44 |
|
2018
Q3 | $524K | Hold |
6,787
| – | – | 0.19% | 42 |
|
2018
Q2 | $481K | Hold |
6,787
| – | – | 0.17% | 48 |
|
2018
Q1 | $512K | Hold |
6,787
| – | – | 0.17% | 47 |
|
2017
Q4 | $486K | Hold |
6,787
| – | – | 0.14% | 50 |
|
2017
Q3 | $550K | Hold |
6,787
| – | – | 0.23% | 35 |
|
2017
Q2 | $480K | Hold |
6,787
| – | – | 0.21% | 39 |
|
2017
Q1 | $461K | Hold |
6,787
| – | – | 0.13% | 94 |
|
2016
Q4 | $486K | Hold |
6,787
| – | – | 0.17% | 40 |
|
2016
Q3 | $537K | Hold |
6,787
| – | – | 0.21% | 37 |
|
2016
Q2 | $566K | Hold |
6,787
| – | – | 0.27% | 35 |
|
2016
Q1 | $623K | Buy |
+6,787
| New | +$623K | 0.39% | 28 |
|